{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:45:10Z","timestamp":1782823510350,"version":"3.54.5"},"reference-count":26,"publisher":"FapUNIFESP (SciELO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Bras. Dermatol."],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1590\/abd1806-4841.20142869","type":"journal-article","created":{"date-parts":[[2014,8,30]],"date-time":"2014-08-30T19:30:55Z","timestamp":1409427055000},"page":"729-734","source":"Crossref","is-referenced-by-count":47,"title":["Efficacy and safety of methotrexate in alopecia areata"],"prefix":"10.1590","volume":"89","author":[{"given":"Mariana","family":"Hammerschmidt","sequence":"first","affiliation":[{"name":"Universidade Federal do Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiane","family":"Mulinari Brenner","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1590\/S0365-05962005000100009","article-title":"Alopecia areata: a revision and update","volume":"80","author":"Rivitti E","year":"2005","journal-title":"An Bras Dermatol"},{"key":"ref2","first-page":"177","article-title":"Alopecia areata update - Part I. Clinical picture, histopatology and pathogenesis","volume":"62","author":"Alkhalifah A","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"ref3","series-title":"Censo Dermatologico da SBD"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jaad.2006.05.008","article-title":"Alopecia areata: A long term follow-up study of 191 patients","volume":"55","author":"Tosti A","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1172\/JCI31942","article-title":"Lymphocytes, neuropeptides, and genes involved in alopecia areata","volume":"117","author":"Gilhar A","year":"2007","journal-title":"J Clin Invest"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/928030","article-title":"Cytokines and Other Mediators in Alopecia Areata","volume":"2010","author":"Gregoriou S","year":"2010","journal-title":"Mediators Inflamm"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaad.2009.10.031","article-title":"Alopecia areata update, Part II. Treatment","volume":"62","author":"Alkhalifah A","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jaad.2005.09.010","article-title":"The use of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia totalis or universalis","volume":"55","author":"Joly P","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"ref9","first-page":"507","article-title":"Long-term follow-up of the efficacy of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia areata totalis or universalis","volume":"137","author":"Chartaux E","year":"2010","journal-title":"Ann Dermatol Venereol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000339341","article-title":"Interest of High-Dose Pulse Corticosteroid Therapy Combined with Methotrexate for Severe Alopecia Areata: A Retrospective Case Series","volume":"224","author":"Droitcourt C","year":"2012","journal-title":"Dermatology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2133.2011.10383.x","article-title":"Efficacy and tolerability of methotrexate in severe childhood AA","volume":"165","author":"Royer M","year":"2011","journal-title":"Br J Dermatol"},{"key":"ref12","first-page":"11","article-title":"A Teia de Toxicidade do Metotrexato","volume":"34","author":"Neves C","year":"2009","journal-title":"Acta Reumatol Port"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/S0365-05962010000100002","article-title":"Immunosuppressive agents in Dermatology","volume":"85","author":"Bressan AL","year":"2010","journal-title":"An Bras Dermatol"},{"key":"ref14","first-page":"1018","article-title":"III Brazilian Thoracic Association Guidelines on Tuberculosis","volume":"35","author":"Conde MB","year":"2009","journal-title":"J Bras Pneumol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2133.2008.08876.x","article-title":"Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review","volume":"160","author":"Prey S","year":"2009","journal-title":"Br J Dermatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2036.2006.03047.x","article-title":"Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent","volume":"24","author":"Berends MA","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1067\/mjd.2001.117047","article-title":"Treatment of psoriasis. Part 2. Systemic therapies","volume":"45","author":"Lebwohl M","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1590\/S0365-05962004000300002","article-title":"Systemic treatment of psoriasis - Part I: methotrexate and acitretin","volume":"79","author":"Martins G. A","year":"2004","journal-title":"An Bras Dermatol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1365-2036.2004.01819.x","article-title":"Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?","volume":"19","author":"Aithal GP","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1468-3083.2007.02322.x","article-title":"Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages","volume":"22","author":"Carneiro SC","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0190-9622(98)70508-0","article-title":"Methotrexate in psoriasis: consensus conference","volume":"38","author":"Roenigk HH","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1067\/mjd.2001.117047","article-title":"Treatment of psoriasis. Part 2. Systemic therapies","volume":"45","author":"Lebwohl M","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2165\/00128071-200506060-00003","article-title":"Monitoring Liver Function during Methotrexate Therapy for Psoriasis. Are Routine Biopsies Really Necessary?","volume":"6","author":"Thomas JA","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1468-3083.2011.03991.x","article-title":"Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity","volume":"25","author":"Montaudie H","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1468-3083.2010.03932.x","article-title":"Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic","volume":"25","author":"Barker J","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jhep.2010.04.043","article-title":"Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: A case-control study","volume":"53","author":"Laharie D","year":"2010","journal-title":"J Hepatol"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abd\/v89n5\/0365-0596-abd-89-05-0729.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:42Z","timestamp":1747666842000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0365-05962014000500729&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0365-05962014000500729"],"URL":"https:\/\/doi.org\/10.1590\/abd1806-4841.20142869","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}